Results 101 to 110 of about 16,198,215 (212)

Bridging the Gap: Treating Opioid Use Disorder in Primary Care

, 2022
Purpose: This article explores the feasibility of treating Opioid Use Disorder (OUD) in primary care and the benefits and barriers to providing this treatment in this setting. Method: A PubMed literature search was conducted of the following search terms:
Miller, Karla H
core   +1 more source

Opioid withdrawal syndrome‐associated cognitive impairment: A narrative review

The American Journal on Addictions, Volume 35, Issue 6, Page 661-672, November 2026.
Abstract Background and Objectives Opioid withdrawal syndrome (OWS) comprises a transient constellation of subjective symptoms and objective signs expressed by brain and other organs. Although cognitive impairment is well documented in opioid use and addiction, little is known about cognitive impairment that may specifically accompany OWS.
Faizan Khan, Nazli Tunali, R. Andrew Chambers   +2 more
wiley   +1 more source

Patients with opioid use disorder choosing treatment with extended-release naltrexone: a 6-month naturalistic study.

INTRODUCTION: The treatment efficacy of extended-release naltrexone (XR-NTX) for opioid use disorder (OUD) has been demonstrated in several studies, but not in naturalistic settings where opioid agonist treatment (OAT) is freely accessible.
Tanum, Lars, Mordal, Jon, Løberg, Else-Marie, Solli, Kristin K, Waleur, Karin Merethe, Brenna, Ida Halvorsen, Weimand, Bente, Benth, Jūratė Šaltytė   +7 more
core   +1 more source

Opioid Use Disorder: Decision Support for Healthcare Professionals [PDF]

, 2020
Opioid Use Disorder (OUD) is defined as deviating from the physician’s prescription of a specific opioid. The OUD patients will require expensive inpatient treatment followed by a long-term outpatient treatment.
Singh, Neetu, Varshney, Upkar
core  

Computer-Based Learning for Opioid Use Disorder [PDF]

, 2022
Over the last several decades, the prevalence of Opioid Use Disorder (OUD) has escalated in the U.S., leading to an opioid epidemic that ravages the wellbeing of the nation. Despite all alleviating efforts, opioid-related morbidity and mortality continue
Bentz, Jordan Taylor, Snell, April
core  

The Association of Opioid Prescribing Continuity and the Risk of Opioid Use Disorder among Older Adults [PDF]

Study objective: To evaluate the association between opioid prescribing continuity and risk of opioid use disorder (OUD) among older Medicare beneficiaries on long term opioid therapy (LTOT).https://egrove.olemiss.edu/pharm_annual_posters_2025/1000 ...
Ramachandran, Sujith, Prajapati, Prachi, Bhattacharya, Kaustuv, Maharjan, Shishir, Bazzazzadehgan, Shadi, Bentley, John P., Yang, Yi   +6 more
core   +1 more source

The Impact of Heterogeneity in Individual Characteristics and Motivation to Quit Heroin Use on Contingency Management and Opioid Agonist Treatment Response: A Latent Class Analysis

Drug and Alcohol Review, Volume 45, Issue 7, November 2026.
ABSTRACT Introduction Contingency Management (CM) involves the systematic application of positive reinforcement (financial incentives) to promote behaviour change, to improve treatment outcomes for individuals with opioid use disorder (OUD). To better understand patient heterogeneity, this study sought to identify meaningful subgroups/classes ...
Louise MacGregor, Timothy Weaver, John Strang, Stephen Pilling, Nicola Metrebian, Kimberley Goldsmith   +5 more
wiley   +1 more source

Assessment and evidence-based treatments for opioid use disorder [PDF]

Clinician Outreach and Communication Activity (COCA) conference call Tuesday, November 29, 2016.One substantial risk associated with prescribing opioids for chronic pain is opioid use disorder (OUD).

core  

Found in translation: orexin receptor antagonism for the treatment of opioid use disorder

Translational Psychiatry
Existing pharmacological treatment options for opioid use disorder (OUD) face challenges that limit their efficacy. Accumulating preclinical evidence implicates the orexin/hypocretin system in numerous aspects of OUD development and symptomology: opioid ...
Joel S. Raymond, Robin D. Vareed, Jamie Peters, Morgan H. James   +3 more
doaj   +1 more source

Associations Between Pain Severity and Opioid Agonist Treatment Among People With Drug Injection Experience in Australia

Drug and Alcohol Review, Volume 45, Issue 7, November 2026.
ABSTRACT Introduction Pain is highly prevalent among people with opioid use disorder (OUD), yet it is often undertreated. Whether opioid agonist treatment (OAT) improves pain outcomes is unknown among this target population. This research aimed to explore associations between pain severity and current OAT status in a longitudinal cohort of people who ...
Jie Yang, Louisa Picco, Paul Dietze, Peter Higgs, Suzanne Nielsen   +4 more
wiley   +1 more source